Advertisement

Topics

Latest "MAQUET Cardiovascular" News Stories

02:41 EDT 21st September 2018 | BioPortfolio

Here are the most relevant search results for "MAQUET Cardiovascular" found in our extensive news archives from over 250 global news sources.

More Information about MAQUET Cardiovascular on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MAQUET Cardiovascular for you to read. Along with our medical data and news we also list MAQUET Cardiovascular Clinical Trials, which are updated daily. BioPortfolio also has a large database of MAQUET Cardiovascular Companies for you to search.

Showing "MAQUET Cardiovascular" News Articles 1–25 of 2,700+

Relevant

Traditional Chinese medicine is widely used for cardiovascular disease

(Cardiovascular Innovations and Applications) In this Letter to the Editor, the authors comment on a review article which assesses the efficacy and safety of TCM for cardiovascular disease, as well as the pharmacological effects of active TCM ingredients on the cardiovascular system and potential mechanisms.


FDA Issues Recall of Maquet Datascope CARDIOSAVE Hybrid IABPs

Fluids spilled on the consoles might seep inside and corrode circuit boards or otherwise cause the intra-aortic balloon pump systems to malfunction, regulators say. News Alerts

Use of bivalirudin for anticoagulation in interventional cardiovascular procedures

(Cardiovascular Innovations and Applications) In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 2, 2018, pp. 149-162(14); DOI: 10.15212/CVIA.2017.0045 Zhen Ge, Jaya Chandrasekhar and Roxana Mehran from the Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, N.Y., USA consider the use of bivalirudin for anticoagu...


Multivitamins Don't Appear to Boost Cardiovascular Health

Taking a daily multivitamin is not associated with lower risk for adverse cardiovascular outcomes, according to a meta-analysis in Circulation: Cardiovascular Quality and Outcomes...

Managing dyslipidaemia for the primary prevention of cardiovascular disease

What you need to knowAssess lipid status as part of an overall cardiovascular risk assessment using a risk calculatorRoutinely record a family history of premature cardiovascular disease, and...

Cardiovascular Nutrition Demystified

The authors of this review of key nutritional studies compiled evidence-based information on foods and dietary patterns that support cardiovascular health and demystified those that have incorrectly been identified as beneficial to cardiovascular health.

Omega-3 fats Supplements Effect on Cardiovascular Health: EPA and DHA has little or no effect on Mortality or Cardiovascular Health 

Omega-3 fats Supplements Effect on Cardiovascular Health: EPA and DHA has little or no effect on Mortality or Cardiovascular Health Reporter: Aviva Lev-Ari, PhD, RN   Cochrane Database Syst Rev. 2018 Jul 18;7:CD003177. doi: 10.1002/14651858.CD003177.pub3. [Epub ahead of print] Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Abdelhamid AS1, Brown TJ,...

Media registration now open for TCT 2018

(Cardiovascular Research Foundation) Media registration is now open online for TCT 2018 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF). TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine, attracting more than 10,000 attendees from 90 countries all over the world.

Racial/ethnic disparities in cardiovascular health persist in U.S. adults

1. Trends from 1988 to 2014 data suggest that for U.S. adults, cardiovascular health has worsened, and health disparities in race/ethnicity and nativity continue to exist. 2. Although cardiovascular health disparities between whites and African Americans or Mexican Americans have decreased, declining cardiovascular health among whites appears to be the reason for these decreases rather […]

Weight Loss Drug Does Not Found to Increase Cardiovascular Events

NewsResearchers discovered a breakthrough weight loss drug that proves to be the first that demonstrates cardiovascular safety in a dedicated cardiovascular outcomes trial.

Weight Loss Drug Not Found to Increase Cardiovascular Events

NewsResearchers discovered a breakthrough weight loss drug that proves to be the first that demonstrates cardiovascular safety in a dedicated cardiovascular outcomes trial.

Relation of Nutrition with Cardiovascular Health

Reporter and Curator: Dr. Sudipta Saha, Ph.D.   A heart-healthy diet has been the basis of atherosclerotic cardiovascular disease (ASCVD) prevention and treatment for decades. The potential cardiovascular (CV) benefits of specific individual components of the “food-ome” (defined as the vast array of foods and their constituents) are still incompletely understood, and nutritional science c...

Review: Plant-based diets associated with better cardiovascular health

Vegetarian, especially vegan, diets are associated with better cardiovascular health, according to a new review published in the journal Progress in Cardiovascular Diseases.

Portugal saves money with increased use of cardiovascular generics

Cardiovascular diseases are the primary cause of mortality worldwide [1-3], accounting for over 30% of all deaths. However, in the last few decades, the number of deaths attributed to cardiovascular diseases in higher-income countries has been on the decline. This is thought to be largely due to improved and increased healthcare interventions, according to Gama et al. [4].

Cardiovascular Risk Reduction

Cardiovascular risk reduction clinical information, medical news, and guidelines. Includes latest research, journal articles, Medscape TV, cases, quizzes, and peer discussion of cardiovascular risk. Medscape

Announcing the TCT 2018 Press Conference Schedule

(Cardiovascular Research Foundation) The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and late-breaking clinical science that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. TCT, the world's premier educational meeting specializing in interventional cardiovascular medicine, will tak...

Announcing the TCT 2018 Late-Breaking Trials

(Cardiovascular Research Foundation) The Cardiovascular Research Foundation (CRF) has announced the 15 late-breaking trials and 12 late-breaking clinical science presentations that will be reported at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. TCT, the world's premier educational meeting specializing in interventional cardiovascular medicine, will take place Sep...

Portugal increases use of generics for treatment of cardiovascular diseases

In Portugal, the use of medicines for cardiovascular system increased nearly two-fold between 2000 and 2010. As such, over a quarter of the overall expenditure on medicines during these years went towards the treatment of cardiovascular issues [1]. However, it is possible that there may be room for cost saving on these medicines through increased uptake of generic and essential medicines. A recent...

Expect much more from AstraZeneca in the cardiovascular space, says Elisabeth Björk

Cardiovascular (CV) disease is the world’s biggest killer that will demand a specific and concerted…

AHA: Limited Health Literacy Is Barrier to Cardiovascular Care

TUESDAY, June 5, 2018 -- Limited health literacy is a barrier to cardiovascular health and prevention of cardiovascular disease (CVD), according to a scientific statement from the American Heart Association published online June 4 in...

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

ABSTRACTRheumatoid arthritis is a systemic autoimmune disease characterized by excess morbidity and mortality from cardiovascular disease. Mechanisms linking rheumatoid arthritis and cardiovascular...

Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events

BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health,  announced today that its REDUCE-IT cardiovascular outcomes study of Vascepa® (icosapent ethyl) is estimated to have reached the onset of the targeted 1,...

Omega-3 supplements do not protect against cardiovascular disease, meta-analysis shows

A meta-analysis of 79 trials showed that increasing long-chain omega-3 had little or no effect on death from all causes, cardiovascular deaths, cardiovascular events, coronary heart disease deaths, stroke or arrhythmia.

Adults aged over 45 with psychological distress may have high risk of cardiovascular disease

Adults ages 45 or older who experience psychological distress such as depression and anxiety may have an increased risk of developing cardiovascular disease, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

Amarin’s REDUCE-IT Clinical Study Now Positioned to be Next Large Cardiovascular Outcomes Study to Report Results

Amarin (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today commented that following this week’s European Society of Cardiology (ESC) Congress in Munich, Germany, Amarin’s landmark cardiovascular outcomes study, REDUCE-IT, is now likely to be the next large cardiovascular outcomes study to report re...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks